Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 30;520(7549):702-5.
doi: 10.1038/nature14138. Epub 2015 Feb 9.

Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9

Affiliations

Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9

Umeharu Ohto et al. Nature. .

Abstract

Innate immunity serves as the first line of defence against invading pathogens such as bacteria and viruses. Toll-like receptors (TLRs) are examples of innate immune receptors, which sense specific molecular patterns from pathogens and activate immune responses. TLR9 recognizes bacterial and viral DNA containing the cytosine-phosphate-guanine (CpG) dideoxynucleotide motif. The molecular basis by which CpG-containing DNA (CpG-DNA) elicits immunostimulatory activity via TLR9 remains to be elucidated. Here we show the crystal structures of three forms of TLR9: unliganded, bound to agonistic CpG-DNA, and bound to inhibitory DNA (iDNA). Agonistic-CpG-DNA-bound TLR9 formed a symmetric TLR9-CpG-DNA complex with 2:2 stoichiometry, whereas iDNA-bound TLR9 was a monomer. CpG-DNA was recognized by both protomers in the dimer, in particular by the amino-terminal fragment (LRRNT-LRR10) from one protomer and the carboxy-terminal fragment (LRR20-LRR22) from the other. The iDNA, which formed a stem-loop structure suitable for binding by intramolecular base pairing, bound to the concave surface from LRR2-LRR10. This structure serves as an important basis for improving our understanding of the functional mechanisms of TLR9.

PubMed Disclaimer

References

    1. Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):271-81 - PubMed
    1. J Exp Med. 2011 Apr 11;208(4):643-51 - PubMed
    1. Nature. 2000 Dec 7;408(6813):740-5 - PubMed
    1. Nat Immunol. 2008 Dec;9(12):1407-14 - PubMed
    1. Annu Rev Immunol. 2002;20:197-216 - PubMed

Publication types